Chemical design of peripherally acting compounds.

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Neuroscience

Background:

• Guanidine derivatives, including mianserin and WAL 801, are structurally related to compounds with known biological activity.
• Previous studies indicated that charged ionic groups influence the central nervous system (CNS) activity of guanidine-related compounds.

Purpose of the Study:

• To synthesize novel guanidine derivatives with potential as peripherally acting 5-HT2 antagonists.
• To explore the use of computer-aided molecular modeling in defining a 5-HT2 pharmacophore.
• To apply the principle of CNS exclusion for the development of peripherally acting analgesics.

Main Methods:

• Synthesis of novel guanidine compounds.
• Utilizing computer-aided molecular modeling to identify a 5-HT2 pharmacophore.
• Designing molecules with polar groups to limit CNS penetration.

Main Results:

• Several synthesized guanidine derivatives demonstrated potent peripheral 5-HT2 antagonism.
• A 5-HT2 pharmacophore model was successfully established using molecular modeling.
• The CNS exclusion principle was validated in the design of a peripherally acting analgesic.

Conclusions:

• Novel guanidines can be designed as selective peripheral 5-HT2 antagonists.
• Molecular modeling is a valuable tool for pharmacophore elucidation.
• The strategy of incorporating polar groups effectively directs biological activity to the periphery, enabling the development of targeted analgesics.